Clinical Trial Update: Efficacy and Safety Study of NeuroStar TMS Therapy in Patients With Major Depressive Disorder With Postpartum Onset [NA]

View source ↗

Summary

A clinical trial evaluating NeuroStar TMS Therapy for major depressive disorder with postpartum onset was terminated, with results subsequently posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Postpartum Depression

Drugs mentioned

• NeuroStar TMS Therapy

Snippet

Sponsor: Neuronetics | Conditions: Depression, Postpartum | NA | Status: TERMINATED | Results posted: 2025-02-10